Glucocorticoids (GCs) modulate the somatotropic axis at a genomic and
a non-genomic level. Critical concentrations of steroids not only dete
rmine somatotrope differentiation but also enhance growth hormone (GH)
gene expression. At a cellular level GH-releasing hormone (GHRH) and
somatostatin (SS) are the two principal neuropeptides involved in the
release of GH. In vitro data indicates that steroids enhance GH releas
e by altering the affinity and the density of GHRH receptors. In addit
ion, they reduce the sensitivity of the somatotrope to SS and decrease
IGF-1 induced negative feedback on GH secretion. The net effect is an
enhancement of GH release.